![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
F.i.s. - Fabbrica Italiana Sintetici S.p.a. Montecchio Maggiore It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Oxazepam, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2011-014 - Rev 02
This Chemical Type CEP, issued on June 19, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 778 associated with this CEP further emphasizes